Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin vs Placebo in Resistant Papular-pustular Rosacea
NCT00882531Phase 3Completed
- Sponsor
- Laboratoires Bailleul
- Start
- Feb 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in papulopustular rosacea comparing Isotretinoin with Placebo (2 arms). Primary endpoint: Response Rate (at least 90% reduction in papular-pustular lesions) at 4 months. Started Feb 2007; status: completed.
02
Drugs
isotretinoin
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT00882531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00882531.